References
- Broughton JP, Deng X, Yu G, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020;38(7):870–874.
- Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473.
- Pouya F, Imani Saber Z, Kerachian MA. Molecular aspects of co-morbidities in COVID-19 Infection. Arch Bone Jt Surg. 2020;8:226–230.
- Coronavirus disease (COVID-19), Weekly Epidemiological Update. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201005-weekly-epi-update-8.pdf.
- Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China - key questions for impact assessment. N Engl J Med. 2020;382(8):692–694.
- Hou T, Zeng W, Yang M, et al. Development and evaluation of a CRISPR-based diagnostic for 2019-novel coronavirus. PLoS Pathog. 2020;16(8):e1008705.
- Fauci AS, Lane HC, Redfield RR. Covid-19 - navigating the uncharted. N Engl J Med. 2020;382(13):1268–1269.
- Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–936.
- Wei WE, Li Z, Chiew CJ, et al. Presymptomatic transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411–415.
- Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–1179.
- Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ. 2020;368:m1165.
- Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ. 2020;369:m1375.
- Kim JM, Kim HM, Lee EJ, et al. Detection and isolation of SARS-CoV-2 in serum, urine, and stool specimens of COVID-19 patients from the Republic of Korea. Osong Public Health Res Perspect. 2020;11(3):112–117.
- Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: what neonatologist need to know. J Med Virol. 2020; 92(6):564–567.
- Han Q, Lin Q, Jin S, et al. Coronavirus 2019-nCoV: a brief perspective from the front line. J Infect. 2020;80(4):373–377.
- Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing for Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296(2):E32–E40.
- Hao W, Li M. Clinical diagnostic value of CT imaging in COVID-19 with multiple negative RT-PCR testing. Travel Med Infect Dis. 2020;34:101627.
- Long C, Xu H, Shen Q, et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol. 2020;126:108961.
- Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295(3):200463–200691.
- Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;296(2):E115–E117.
- Yang W, Yan F. Patients with RT-PCR-confirmed COVID-19 and normal chest CT. Radiology. 2020;295(2):E3–E3.
- Caliendo AM, Hodinka RL. A CRISPR way to diagnose infectious diseases. N Engl J Med. 2017;377(17):1685–1687.
- Li C, Ren L. Recent progress on the diagnosis of 2019 Novel Coronavirus. Transbound Emerg Dis. 2020;67(4):1485–1491.
- Li Y, Yao L, Li J, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020;92(7):903–908.
- Abduljalil JM. Laboratory diagnosis of SARS-CoV-2: available approaches and limitations. New Microbes New Infect. 2020;36:100713.
- Ji T, Liu Z, Wang G, et al. Detection of COVID-19: a review of the current literature and future perspectives. Biosens Bioelectron. 2020;166:112455.
- Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844.
- Xie C, Jiang L, Huang G, et al. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis. 2020; 93:264–267.
- Zhu H, Fohlerova Z, Pekarek J, et al. Recent advances in lab-on-a-chip technologies for viral diagnosis. Biosens Bioelectron. 2020;153:112041.
- Habibzadeh P, Sajadi MM, Emami A, et al. Rate of re-positive RT-PCR test among patients recovered from COVID-19. Biochem Med (Zagreb). 2020;30(3):030401.
- Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients recovered from COVID-19. Jama. 2020;323(15):1502–1503.
- Kucirka LM, Lauer SA, Laeyendecker O, et al. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020;173(4):262–267.
- Tang YW, Schmitz JE, Persing DH, et al. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol. 2020;58(6):e00512–20.
- Chertow DS. Next-generation diagnostics with CRISPR. Science. 2018;360(6387):381–382.
- Li Y, Li S, Wang J, et al. CRISPR/Cas systems towards next-generation biosensing. Trends Biotechnol. 2019;37(7):730–743.
- Ding X, Yin K, Li Z, et al. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nat Commun. 2020;11:4711.
- Kaminski MM, Alcantar MA, Lape IT, Greensmith R, et al. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection. Nat Biomed Eng. 2020;4(6):601–609.
- Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019;20(8):490–507.
- Yin H, Xue W, Anderson DG. CRISPR-Cas: a tool for cancer research and therapeutics. Nat Rev Clin Oncol. 2019;16(5):281–295.
- Lee SH, Park YH, Jin YB, et al. CRISPR diagnosis and therapeutics with single base pair precision. Trends Mol Med. 2020;26(3):337–350.
- Cox DBT, Gootenberg JS, Abudayyeh OO, et al. RNA editing with CRISPR-Cas13. Science. 2017;358(6366):1019–1027.
- Cho SW, Kim S, Kim Y, et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res. 2014;24(1):132–141.
- Makarova KS, Wolf YI, Iranzo J, et al. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol. 2020;18(2):67–83.
- Terns MP. CRISPR-based technologies: impact of RNA-targeting systems. Mol Cell. 2018;72(3):404–412.
- O'Connell MR, Oakes BL, Sternberg SH, et al. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature. 2014;516(7530):263–266.
- Dugar G, Leenay RT, Eisenbart SK, et al. CRISPR RNA-dependent binding and cleavage of endogenous RNAs by the Campylobacter jejuni Cas9. Mol Cell. 2018;69(5):893–905.e897.
- Strutt SC, Torrez RM, Kaya E, et al. RNA-dependent RNA targeting by CRISPR-Cas9. Elife. 2018;7:e32724.
- Zhou L, Peng R, Zhang R, et al. The applications of CRISPR/Cas system in molecular detection. J Cell Mol Med. 2018;22(12):5807–5815.
- Pardee K, Green AA, Takahashi MK, et al. Rapid, low-cost detection of Zika virus using programmable biomolecular components. Cell. 2016;165(5):1255–1266.
- Guk K, Keem JO, Hwang SG, et al. A facile, rapid and sensitive detection of MRSA using a CRISPR-mediated DNA FISH method, antibody-like dCas9/sgRNA complex. Biosens Bioelectron. 2017;95:67–71.
- Chen JS, Ma E, Harrington LB, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018;360(6387):436–439.
- Swarts DC, Jinek M. Mechanistic insights into the cis- and trans-acting DNase activities of Cas12a. Mol Cell. 2019;73(3):589–600.
- Teng F, Cui T, Feng G, et al. Repurposing CRISPR-Cas12b for mammalian genome engineering. Cell Discov. 2018;4:63.
- Shmakov S, Abudayyeh OO, Makarova KS, et al. Discovery and functional characterization of diverse Class 2 CRISPR-Cas systems. Mol Cell. 2015;60(3):385–397.
- Harrington LB, Burstein D, Chen JS, et al. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science. 2018;362(6416):839–842.
- Aquino-Jarquin G. CRISPR-Cas14 is now part of the artillery for gene editing and molecular diagnostic. Nanomedicine. 2019;18:428–431.
- O'Connell MR. Molecular mechanisms of RNA targeting by Cas13-containing Type VI CRISPR-Cas systems. J Mol Biol. 2019;431(1):66–87.
- East-Seletsky A, O'Connell MR, Knight SC, et al. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature. 2016;538(7624):270–273.
- Xiong Y, Zhang J, Yang Z, et al. Functional DNA regulated CRISPR-Cas12a sensors for point-of-care diagnostics of non-nucleic-acid targets. J Am Chem Soc. 2020;142(1):207–213.
- Zetsche B, Gootenberg JS, Abudayyeh OO, et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 2015;163(3):759–771.
- Li L, Li S, Wu N, et al. HOLMESv2: a CRISPR-Cas12b-assisted platform for nucleic acid detection and DNA methylation quantitation. ACS Synth Biol. 2019;8(10):2228–2237.
- Kerachian MA, Azghandi M, Javadmanesh A, et al. Selective capture of plasma cell-free tumor DNA on magnetic beads: a sensitive and versatile tool for liquid biopsy. Cell Oncol (Dordr). 2020;43:949–956.
- Kerachian MA, Poudineh A, Thiery JP. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine. Crit Rev Oncol Hematol. 2019; 144:102827.
- Gootenberg JS, Abudayyeh OO, Lee JW, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017;356(6336):438–442.
- Myhrvold C, Freije CA, Gootenberg JS, et al. Field-deployable viral diagnostics using CRISPR-Cas13. Science. 2018;360(6387):444–448.
- Gootenberg JS, Abudayyeh OO, Kellner MJ, Joung J, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018;360(6387):439–444.
- Metsky HC, Freije CA, Kosoko-Thoroddsen T-SF, et al. CRISPR-based COVID-19 surveillance using a genomically-comprehensive machine learning approach. bioRxiv. 2020. DOI:https://doi.org/10.1101/2020.02.26.967026
- A protocol for detection of COVID-19 using CRISPR diagnostics. Available from: https://www.broadinstitute.org/files/publications/special/COVID-19%20detection%20(updated).pdf
- Joung J, Ladha A, Saito M, et al. Detection of SARS-CoV-2 with SHERLOCK one-pot testing. N Engl J Med. 2020;383(15):1492–1494.
- Joung J, Ladha A, Saito M, et al. Point-of-care testing for COVID-19 using SHERLOCK diagnostics. medRxiv. 2020. DOI:https://doi.org/10.1101/2020.05.04.20091231
- Rauch JN, Valois E, Solley SC, et al. A scalable, easy-to-deploy, protocol for Cas13-based detection of SARS-CoV-2 genetic material. bioRxiv. 2020. DOI:https://doi.org/10.1101/2020.04.20.052159
- Bai J, Lin H, Li H, et al. Cas12a-based on-site and rapid nucleic acid dDetection of African swine fever. Front Microbiol. 2019;10:2830.
- Li SY, Cheng QX, Wang JM, et al. CRISPR-Cas12a-assisted nucleic acid detection. Cell Discov. 2018;4:20.
- Teng F, Guo L, Cui T, et al. CDetection: CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity. Genome Biol. 2019;20(1):132.
- Guo L, Sun X, Wang X, et al. SARS-CoV-2 detection with CRISPR diagnostics. Cell Discov. 2020;6:34.
- Wang X, Zhong M, Liu Y, et al. Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER. Sci Bull (Beijing). 2020;65(17):1436–1439.
- Huang M, Zhou X, Wang H, et al. Clustered regularly interspaced short palindromic repeats/Cas9 triggered isothermal amplification for site-specific nucleic acid detection. Anal Chem. 2018;90(3):2193–2200.
- Zhang B, Wang Q, Xu X, et al. Detection of target DNA with a novel Cas9/sgRNAs-associated reverse PCR (CARP) technique. Anal Bioanal Chem. 2018;410(12):2889–2900.
- Zhang B, Xia Q, Wang Q, et al. Detecting and typing target DNA with a novel CRISPR-typing PCR (ctPCR) technique. Anal Biochem. 2018;561-562:37–46.
- Azhar M, Phutela R, Ansari AH, et al. Rapid, field-deployable nucleobase detection and identification using FnCas9. bioRxiv. 2020. DOI:https://doi.org/10.1101/2020.04.07.028167
- Sherlock CRISPR SARS-CoV-2 Kit, Sherlock BioSciences, Inc. Available from: https://www.fda.gov/media/137747/download
- Lucia C, Federico P-B, Alejandra GC. An ultrasensitive, rapid, and portable coronavirus SARS-CoV-2 sequence detection method based on CRISPR-Cas12. bioRxiv. 2020. DOI:https://doi.org/10.1101/2020.02.29.971127
- Esbin MN, Whitney ON, Chong S, et al. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. RNA. 2020;26(7):771–783.
- Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602–608.
- Drain PK, Hyle EP, Noubary F, et al. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2014;14(3):239–249.
- Nayak S, Blumenfeld NR, Laksanasopin T, et al. Point-of-care diagnostics: recent developments in a connected age. Anal Chem. 2017;89(1):102–123.
- Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):e63.
- Huang Z, Tian D, Liu Y, et al. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosens Bioelectron. 2020;164:112316.
- Chavez A, Pruitt BW, Tuttle M, et al. Precise Cas9 targeting enables genomic mutation prevention. Proc Natl Acad Sci USA. 2018;115(14):3669–3673.
- Van Ness J, Van Ness LK, Galas DJ. Isothermal reactions for the amplification of oligonucleotides. Proc Natl Acad Sci U S A. 2003;100(8):4504–4509.
- Mok E, Wee E, Wang Y, et al. Comprehensive evaluation of molecular enhancers of the isothermal exponential amplification reaction. Sci Rep. 2016;6:37837.
- van Dongen JE, Berendsen JTW, Steenbergen RDM, et al. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities. Biosens Bioelectron. 2020. 166:112445.
- Mina MJ, Parker R, Larremore DB. Rethinking Covid-19 test sensitivity - a strategy for containment. N Engl J Med. 2020. DOI:https://doi.org/10.1056/NEJMp2025631
- He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–675.
- De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev. 2016;29(3):695–747.
- Liu X, Hao R, Chen S, et al. Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome. J Gen Virol. 2015;96(8):2252–2261.
- Price AA, Sampson TR, Ratner HK, et al. Cas9-mediated targeting of viral RNA in eukaryotic cells. Proc Natl Acad Sci USA. 2015;112(19):6164–6169.
- Ramanan V, Shlomai A, Cox DB, et al. CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus. Sci Rep. 2015;5:10833.
- Roehm PC, Shekarabi M, Wollebo HS, et al. Inhibition of HSV-1 replication by gene editing strategy. Sci Rep. 2016;6:23146.
- Yin C, Zhang T, Qu X, et al. In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models. Mol Ther. 2017;25(5):1168–1186.
- Ophinni Y, Inoue M, Kotaki T, et al. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures. Sci Rep. 2018;8(1):7784.
- Freije CA, Myhrvold C, Boehm CK, et al. Programmable inhibition and detection of RNA viruses using Cas13. Mol Cell. 2019;76(5):826–837.e811.
- Abbott TR, Dhamdhere G, Liu Y, et al. Development of CRISPR as an antiviral Strategy to combat SARS-CoV-2 and influenza. Cell. 2020;181(4):865–876.e812.
- Nguyen TM, Zhang Y, Pandolfi PP. Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses. Cell Res. 2020;30(3):189–190.
- Blanchard EL, Vanover D, Bawage SS, et al. Treating influenza and SARS-CoV-2 via mRNA-encoded Cas13a. bioRxiv. 2020. DOI:https://doi.org/10.1101/2020.04.24.060418
- Fineberg HV. Ten weeks to crush the curve. N Engl J Med. 2020;382(17):e37.
- Tromberg BJ, Schwetz TA, Perez-Stable EJ, et al. Rapid scaling up of Covid-19 diagnostic testing in the United States - the NIH RADx initiative. N Engl J Med. 2020;383(11):1071–1077.
- Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease. Clin Infect Dis 2020. DOI:https://doi.org/10.1093/cid/ciaa344
- Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–236.
- Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020;71(15):778–785.
- Guo X, Guo Z, Duan C, et al. Long-term persistence of IgG antibodies in SARS-CoV infected healthcare workers. medRxiv. 2020. DOI:https://doi.org/10.1101/2020.02.12.20021386
- Ding X, Xu Z, Yin K, et al. Dual-priming isothermal amplification (DAMP) for highly sensitive and specific molecular detection with ultralow nonspecific signals. Anal Chem. 2019;91(20):12852–12858.